These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6107487)

  • 1. Complement-fixing islet-cell antibodies before and after onset of insulin-dependent diabetes.
    Ilonen J; Mustonen A; Akerblom HK; Huttunen NP
    Lancet; 1980 Oct; 2(8198):805. PubMed ID: 6107487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
    Majkowska L; Czekalski S; Skwira J
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: implications for early screening.
    Chmiel R; Giannopoulou EZ; Winkler C; Achenbach P; Ziegler AG; Bonifacio E
    Diabetologia; 2015 Feb; 58(2):411-3. PubMed ID: 25409656
    [No Abstract]   [Full Text] [Related]  

  • 5. Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins.
    Johnston C; Millward BA; Hoskins P; Leslie RD; Bottazzo GF; Pyke DA
    Diabetologia; 1989 Jun; 32(6):382-6. PubMed ID: 2668086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
    Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
    Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet-cell and insulin autoantibodies in first-degree relatives of type I diabetics: a 5-year follow-up study in a Swiss population.
    Spinas GA; Matter L; Wilkin T; Staffelbach O; Berger W
    Adv Exp Med Biol; 1988; 246():209-14. PubMed ID: 3074652
    [No Abstract]   [Full Text] [Related]  

  • 9. The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases.
    Betterle C; Presotto F; Magrin L; Pedini B; Moro L; Caretto A; Zanchetta R
    Diabetologia; 1994 Jan; 37(1):95-103. PubMed ID: 8150236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic.
    Radillo O; Nocera A; Leprini A; Barocci S; Mollnes TE; Pocecco M; Pausa M; Valente U; Betterle C; Tedesco F
    Clin Immunol Immunopathol; 1996 Jun; 79(3):217-23. PubMed ID: 8635278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage.
    Bottazzo GF; Dean BM; Gorsuch AN; Cudworth AG; Doniach D
    Lancet; 1980 Mar; 1(8170):668-72. PubMed ID: 6103089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
    Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
    Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmunity in the genesis of beta-pancreatic lesions].
    Doniach D; Mirakian R; Dean B; Richardson A; Bottazzo GF
    Journ Annu Diabetol Hotel Dieu; 1984; ():151-62. PubMed ID: 6399531
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin autoantibodies in pre-diabetes.
    Riley WJ; Atkinson MA; MacLaren NK
    Adv Exp Med Biol; 1988; 246():45-51. PubMed ID: 3074667
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.
    Gorsuch AN; Spencer KM; Lister J; McNally JM; Dean BM; Bottazzo GF; Cudworth AG
    Lancet; 1981 Dec 19-26; 2(8260-61):1363-5. PubMed ID: 6118756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin autoimmunity: the rate limiting factor in pre-type I diabetes.
    Eisenbarth GS; Jackson RA; Pugliese A
    J Autoimmun; 1992 Apr; 5 Suppl A():241-6. PubMed ID: 1503616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories.
    Lernmark A; Molenaar JL; van Beers WA; Yamaguchi Y; Nagataki S; Ludvigsson J; Maclaren NK
    Diabetologia; 1991 Jul; 34(7):534-5. PubMed ID: 1916061
    [No Abstract]   [Full Text] [Related]  

  • 19. Islet cell antibodies and complement fixing islet cell antibodies in blood serum of patients with chronic adrenal insufficiency (Addison's disease).
    Gryczyńska M; Majkowska L; Czekalski S
    Endokrynol Pol; 1989; 40(4):155-61. PubMed ID: 2701096
    [No Abstract]   [Full Text] [Related]  

  • 20. [Result of 3 years of screening for preclinical phase of juvenile insulin-dependent diabetes mellitus].
    Lesage C; Boitard C; Carel JC; Dauvergne M; Roger M; Chaussain JL; Bougnères PF
    Arch Fr Pediatr; 1990 Dec; 47(10):709-13. PubMed ID: 2082843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.